Cystine Capacity Clinical Study (CysCap)

NCT02120105 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2018-12-03

No results posted yet for this study

Summary

The purpose of this study is to determine whether urinary cystine capacity, an assay used to measure the amount of cystine in the urine, can be used to predict stone recurrence in patients with cystinuria.

Conditions

  • Cystinuria

Sponsors & Collaborators

Principal Investigators

  • David S Goldfarb, MD · NYU Langone Health

Eligibility

Min Age
8 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2017-02-24
Completion
2017-02-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02120105 on ClinicalTrials.gov